School of Medicine


Showing 801-820 of 5,029 Results

  • Stephanie Chow

    Stephanie Chow

    Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology

    BioDr. Chow is a fellowship-trained gynecologic oncologist. She is a clinical assistant professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.

    She treats the full spectrum of gynecologic cancers, including cervical, endometrial, ovarian, vaginal, and vulvar. She emphasizes minimally invasive treatment and performs laparoscopic and robotic surgery.

    Dr. Chow works closely with radiation oncology, genetics, and other oncologic specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Chow is a strong advocate for patient education and strives to deliver compassionate care to patients and their families.

    Dr. Chow has conducted extensive clinical research. Her work has focused on the role of the sentinel lymph node biopsy technique for gynecologic cancer, therapeutic vaccines for ovarian cancer, the impact of race on the development of uterine cancer, and other topics. She has published in Molecular Cancer Therapeutics, Gynecologic Oncology, Scientific Reports, and other peer-reviewed journals.

    Dr. Chow has also won numerous honors and awards for her scholarship and research achievements. In fellowship, she earned the AACR Doreen J. Putrah Cancer Research Foundation Scholar-In-Training Award. She was also awarded the AAGL Recognition of Excellence in Minimally Invasive Gynecology.

    Dr. Chow is a member of the Society of Gynecologic Oncology (SGO), American Association for Cancer Research (AACR), American Association of Gynecologic Laparoscopists (AAGL), and American College of Obstetricians and Gynecologists (ACOG).

  • Kamilee Christenson, MD

    Kamilee Christenson, MD

    Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General

    Current Research and Scholarly InterestsImproving access to effective birth control. Improving access to safe abortions.

  • Antonios Chronopoulos

    Antonios Chronopoulos

    Instructor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors

  • Alvina Dor-Yan Chu

    Alvina Dor-Yan Chu

    Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.

    She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.

    In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students.

  • Andrew Chu, MD, MPH, MBA

    Andrew Chu, MD, MPH, MBA

    Clinical Assistant Professor, Emergency Medicine

    BioDr. Chu is a board-certified emergency medicine physician and clinical assistant professor in the Department of Emergency Medicine. He is passionate about integrating lean startup methodologies into daily academic practice and has a decade of experience leading multi-disciplinary teams in designing, developing, and launching award-winning healthcare technologies. Dr. Chu is currently working with his colleagues to build AI solutions that will improve clinical operations for the emergency department.

    He is also part of the Stanford EM Partners Program (STEPP), where he evaluates and executes on promising academic-industry partnerships. He is also an active committee member and former co-chair for the Stanford EM Innovation Conference, the premier virtual conference on AI and innovation for the acute care space.

    He completed his residency in emergency medicine at the Harvard affiliated Mass General Brigham program. He received his applied research fellowship in healthcare innovation at Harvard Medical School. He also completed the Stanford Biodesign Faculty Fellowship. He pursued a medical degree at Boston University, a Master of Public Health (MPH) degree at Harvard, and a Master of Business Administration (MBA) degree at the Quantic School of Business and Technology.

    He is a member of the American College of Emergency Physicians, American Academy of Emergency Medicine, and Society of Academic Emergency Medicine.

  • Constance Chu, MD

    Constance Chu, MD

    Professor of Orthopaedic Surgery (Sports Medicine)

    BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.

    As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.

    Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships.

  • Derek Chu, MD

    Derek Chu, MD

    Clinical Associate Professor, Dermatology
    Clinical Associate Professor (By courtesy), Pediatrics

    BioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
    Email: derekchu@stanford.edu

  • Gilbert Chu

    Gilbert Chu

    Professor of Medicine (Oncology) and of Biochemistry

    Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.

  • Lawrence Chu, MD, MS

    Lawrence Chu, MD, MS

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)

    Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.

    For a full description of my educational informatics work, please see my website aim.stanford.edu.

    My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.

    I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.

    The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain.

  • Steven Chu

    Steven Chu

    William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering

    Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water

  • Weihan Chu

    Weihan Chu

    Clinical Assistant Professor, Medicine

    BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.

    Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.

    Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.

    In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.

    Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.

    Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology.

  • Ian Chua

    Ian Chua

    Clinical Associate Professor, Pediatrics

    BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.

  • Katrin Chua

    Katrin Chua

    Professor of Medicine (Endocrinology, Gerontology and Metabolism)
    On Partial Leave from 02/01/2026 To 08/31/2026

    Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.

  • Cynthia Chuang

    Cynthia Chuang

    Clinical Professor, Radiation Oncology - Radiation Physics

    BioEducation:

    1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA

    1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA

    1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA

    1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA

    2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory

    2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)


    Academic Appointments:

    2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California

    2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA

    2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA